Malaria drugs have been on sale at pharmacies across the country for decades.
They’re used to treat people who have malaria but have no symptoms, like diarrhea and fever.
But now a new drug from the pharmacy chain Walgreens is making headlines.
The drug, called Lantus, is a cheaper alternative to the existing drugs and can cure people who don’t have the virus.
A lot of people have taken Lantuses, and there’s even a study that found that those who took it experienced less severe symptoms than people who didn’t take it.
Walgens drug is being used to help control the spread of the virus in India.
A new study by scientists at the University of Pennsylvania found that people who took Lantussan also experienced less fever and diarrhea, and less fever-like symptoms than those who didn.
The findings were published in the American Journal of Tropical Medicine and Hygiene.
Here’s a video showing how Lantaus work.
The study also found that Lantusa could be a boon to people who suffer from the virus who can’t afford expensive new treatments.
“We’re seeing a dramatic improvement in a lot of these people,” said Dr. Peter Fiebert, the lead author of the study.
“In a lot for them, this is a very, very big step.”
Lantosis is not yet FDA-approved for use in the United States.
The company behind it, Walgess Pharmaceuticals, has yet to release an official statement about the new drug, which is being developed by an Indian company called Cebi Pharma.
But Fiebach said that the company is hopeful that it will be approved in the near future.
The news comes just days after Walgarts drug company, Walgreen, announced it had reached a $20 billion deal to buy the drug maker’s drug division.
A spokesperson for Walgrees drug company said in a statement: We look forward to a future partnership with Cebis Pharmaceuticals.
Lantos is also being used in India as a vaccine.
In India, it’s the most commonly used drug in the country, but there are no vaccine options for people who are infected with malaria.
People who take Lantoses medications have less fever, diarrhea, or fatigue.
That means people who do not have malaria are less likely to contract the virus and die.
Walgreen has been working with the Indian government to develop an effective vaccine for the country.
The United States has been the most successful at making vaccines, but India is one of the hardest places to make a vaccine, according to Dr. David Beil, an expert in infectious diseases at the Johns Hopkins Bloomberg School of Public Health.
The vaccine has been available in the U.S. since 2011.
That was the year after the World Health Organization announced the global death toll from malaria rose to almost 4 million.
Dr. Steven L. Goss, a public health expert at the George Washington University, said that there is currently no vaccine available in India, but that the country has been trying to develop one.
“There’s been a tremendous amount of effort on the part of the government, especially the government in India,” Goss said.
“They’re working very closely with Walgreen to make sure that they’re able to make the vaccine.”
India is now the only country on Earth that has tested a vaccine that has shown to be safe for people with malaria and proven to work against the virus, which has killed more than 2.5 million people in India since 2007.
Walgas is the largest drug company in India with nearly 3,000 stores and a total of $14 billion in sales.
It also has its own pharmacy in the city of Indore.
This story has been updated to include comments from Walguss Pharmaceuticals’ public relations representative.